Jefferies Financial Group Inc. Royalty Pharma PLC Transaction History

Jefferies Financial Group Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$27.46 - $31.33 $846,152 - $965,402	-30,814 Reduced 18.36%	137,000 $4.16 Million
Q4 2023 Feb 13, 2024	BUY	$26.21 - $29.22 $3.79 Million - $4.22 Million	144,414 Added 617.15%	167,814 $4.71 Million
Q3 2023 Nov 14, 2023	SELL	$26.26 - $31.38 $2.5 Million - $2.99 Million	-95,330 Reduced 80.29%	23,400 $635,000
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $2.73 Million - $3.37 Million	92,202 Added 347.56%	118,730 $3.65 Million
Q1 2023 May 15, 2023	SELL	$32.77 - $39.4 $751,809 - $903,914	-22,942 Reduced 46.38%	26,528 $955,000
Q4 2022 Sep 21, 2023	SELL	$39.17 - $44.04 $3.39 Million - $3.81 Million	-86,452 Reduced 72.81%	32,278 $1.28 Million
Q4 2022 Feb 14, 2023	BUY	$39.17 - $44.04 $1.94 Million - $2.18 Million	49,470 New	49,470 $1.96 Million

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.